An open innovation program that aims to empower entrepreneurs and digital health businesses to develop disruptive health solutions through the use of digital technologies.
Who are we looking for?
You are passionate about disrupting the health industry using digital technologies.
NEED
You are addressing a real and verified need.
FOCUS
You are focused on Central Nervous System, Cardio-metabolism, Pain, Gastro-intestinal or Oncology (other therapeutic areas will also be considered).
HEALTH
You are developing solutions for patients who are ill or suffering from illness related disabilities (i.e. not wellness).
We at Ferrer believe that digital health is about putting patient’s needs first and developing digital solutions across the patient care value chain (physicians, caregivers, payers, hospitals and so on) to address those needs in a manner that enhances the patient’s human experience. We also recognize that the knowledge and experience of pharma companies needs to be balanced with the creativity and agility of start-ups and small businesses.
Through superⅴpn下载apk program, we aim to create a platform for collaboration between start ups and us to explore digital health solutions together that can build healthier societies.
COUNTDOWN TIMER!
SPRINGCHALLENGE 2023
CHALLENGE_1
Anticipating
movement
disorder crises
Can we use digital technologies to help patients with movement disorders to reliably predict the next crisis such that the patient can take pre-emptive action to avoid or manage the impact of condition?
CHALLENGE_2
Treating cognitive
and behavioural
disorders
Can we use digital technologies to help patients with cognitive and behavioural disorders to improve social adaptation, and vital expectations, while reducing their reliance on caregivers and improving their quality of life?
CHALLENGE_3
Reducing pain severity
and managing drug
dosage
Can we help patients suffering from pain, including those on opioids, manage their pain better through the use of digital technologies?
橡树vp官网
Overview
黑猫v1.4.9破解版-黑猫安卓手机版下载 - 破解网软件下载:2021-7-31 · 黑猫破解版 应用类型:生活必备 发布时间:2021-07-31 15:47:05 应用版本:1.4.9 大小:5.19 MB 应用标签: 生活必备 破解软件 安卓版下载 资源详见介绍 扫描二维码下载 应用截图 应用介绍 黑猫破解版简介 黑猫破解版app是一款很强大的 ...
Movement disorders are characterized by multiple manifestations including but not limited to difficulty moving (walking), speaking and swallowing, twitching or jerking movements, even convulsions, that sometimes can be accompanied by loss of consciousness.1 Because the warning signs of a crisis are not always present or reliably perceived by the patient, there is a need for sensors (wearable, implantable or patch among others) that could detect the warning signs. In this way, the patient would be alerted to an upcoming episode, thereby enabling the patient to take proactive steps such the intake of a medication with fast onset of action.
Challenge
Can we use digital technologies to find a reliable way to predict if a patient is going to have a movement crisis early enough such that the patient is able to take pre-emptive action? Please note that warning signs indicating that a crisis is imminent may include ‘aura’ (pro-drom), psychic symptoms, auditory hallucinations, olfactory hallucinations, numbness, anxiety among others. The solution should allow patients to continue their normal lives with no to minimal interference and may involve all relevant stakeholders in the patient care value chain.
1Abdo, W., van de Warrenburg, B., Burn, D. et al. The clinical approach to movement disorders. Nat Rev Neurol 6, 29–37 (2010). http://doi.org/10.1038/nrneurol.2009.196
橡树vp官网
Overview
Patients suffering from a cognitive and behavioural disorders with a neurological involvement, regardless of whether it has neurodevelopmental1 (ASD, ADHD, NLD,…), neurodegenerative2 (Alzheimer, dementia,..), brain injuries, or tumours origins, heavily rely on their caregivers and therapists for support on daily chores. Typically, therapeutical assistance goes to task for rehabitation of impairments as: vision loss, visuospatial or balance disorders, verbal expression and communicative difficulties, attention or memory deficits, or effective and social skills problems. Digital solutions for these disorders currently focus on cognitive stimulation through games and tests, while solutions that reduce patients’ dependence from caregivers and therapists between patient and doctor, as well as a better quality of life.
Challenge
We would be looking at solutions that allow patients to connect with and leverage relevant stakeholders, to offer more personalized and intensive treatments, to achieve more independence and improved relationships. Can we use digital technologies to help patients with cognitive and behavioural disorders to improve social adaptation, and vital expectations, while reducing their reliance on caregivers and improving their quality of life?
1. The first sub-challenge concerns adult patients with alterations in brain functions due to degenerative processes (dementia, Alzheimer's...), cerebrovascular accidents (ABI), traumas (accidents) or tumour processes. The solution would have to include cognitive rehabilitation or behavioural reeducations programs or treatments to improve their adaptabilities skills and so their performance in life.
2. The second sub-challenge is oriented towards neurodevelopmental disorders (including but not limited to autism spectrum disorders, hyperactivity and attention deficits, language disorders, among others) in children & adults. The solution would be a digital approach for rehabilitation interventions for cognitive impairment attention focus, memory, learning and language development, social skills) and for the associated behavioural or emotional disorders it may also be a treatment of related symptoms (aggressiveness, negativity).
1http://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(16)30376-5/fulltext
2动画《猫和老鼠》(Tom and Jerry)中出现过哪些世界名曲 ...:2021-4-6 · 久违地写个长答案,拯救一下越来越完蛋的知乎动画话题。最高票的问题有许多错误,首先最严重的错误是: 说起这部动画,最经典的名曲配乐是 George Gershwin - Rhapsody in Blue(1924) 简介:乔治·格什温《蓝色狂想曲》,整部猫和老鼠出现过很多次。 ...
橡树vp官网
atom免费版安卓apk
Pain is a psychosomatic response dependent on an objective component (the strength of sensory signal sent to the brain) and a subjective component (a combination of cognitive, emotional and behavioural response) that affects how the pain is perceived and reported.1 As a result, not only patient’s response to pain medication is highly variable but patient’s self-reporting of pain may also be erratic and unreliable making it difficult for the doctor to decide on optimal drug dosage.2 This challenge aims at finding digital technologies for optimal dose-adjustment of pain medications, including opioid treatments, where there is a need to guarantee enough comfort to the patient while reducing the risk of adverse events.
Challenge
Can we improve pain management of patients, including those that rely on opioids, using digital technologies? Can we help doctor-patient relationship and communication by objectivizing reporting of pain? The solution should present a systematic and measurable approach to pain management involving all relevant stakeholders.
1. The first sub-challenge looks at how to predict, detect and reduce opioid misuse to prevent dosage escalation? The solution would involve monitoring the actual dose (i.e. surrogate marker for the concentration of drug in the patients’s body) vs. the actual need of the patient (i.e. captured through digital pain biomarkers). The goal being to ensure that the patient is not under-treated and, at the same time, is not bearing pain.
欧米伽小队 – 专注于分享的精品资源免费下载 – 欢迎加入 ...:2021-6-15 · Tom黑猫v1.4.8会员版 速度超快无限流量 06/18 酷我音乐v9.2.1.4破解版 海外模式全开启音乐免费下载 06/18 小影v7.11.8 直装破解会员国内版_快速拍照分享应用 06/16 WIN10激活+Office2021-2021激活 06/16 计算机一二三四级全部题库.软件模拟 06/15 Win10激活
1http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438523/
2http://www.ncbi.nlm.nih.gov/pubmed/24051610
橡树vp官网
for chronic patients
Deadline: 20/12/2023
Eloi Torcal
Corporate product manager
Claudia Roca
Corporate marketing manager
Overview
Patients who suffer from severe chronic illnesses are often reliant on care givers in order to their maintain quality of life. This loss of freedom coupled with an already stressed care system in many parts of the world leads to a challenging life for many patients.
For example, PAH (Pulmonary Arterial Hypertension) patients currently have a bleak outlook as the disease is progressive and without cure. Patients live an average of 7-10 year from diagnosis and gradually see their mobility decreased. Patients eventually have to rely on continuous infusion pump therapy1 and are completely reliant on their support network (i.e. family members, doctors, nurses and physicians).
Challenge
How can we improve care, for chronic patients such as those suffering from advanced PAH symptoms and reduce the burden on their support network using digital solutions?
- Can we better track and monitor patients through a digitally enhanced solution?
- Can we provide guidance and troubleshoot common issues for patients digitally?
- Can we complement the patient support network, which is primarily face to face, though digital means?
- Can we help patients cope with pain and emotional distress using digital technologies?
- Can we reduce frequent patient visits to care centres for medicine collection and related tests?
快乐返资源网 - Powered by Discuz!:2021-10-13 · jh485924960 2龙猫_v1.0.6_会员破解版已修复[最新版].apk 6666666666666666666 qwertylin 3Tom (黑猫)v1.5.0去广告版.apk ... admin 1Tom (黑猫)v1.5.0去广告版.apk 版块名称:环V游P世N 界 主题分类名称: 总发帖数:0 今日发帖数:0 最后回复时间:2021-03 ...
Deadline: 20/12/2023
Carme Trepat
Head of Marketing
Overview
Half of the patients suffering from silent chronic cardiovascular diseases (CVD) stop taking their medication within 3 months of being diagnosed.1 The silent CVDs include coronary artery diseases, diabetes, cholesterol, hypertension and patients who are at an increased risk of heart attack and stoke (due to a previous event) and are now the leading cause of death.
In order for a person to take an action, three things need to happen first according to Dr. BJ Fogg (a psychologist and founder of Stanford Persuasive Technology Lab). First, the person needs to be motivated to perform the action. Second, the person needs to have the ability to perform that action. Finally, the person needs to have a trigger or a prompt which initiates the action2.
Most of the medical adherence solutions tend to focus on triggers through reminder applications etc. however the majority of non-adherence issues arise from lack of motivation or ability.
蚂蚁vp(永久免费)
How can we improve medication adherence using digital technologies for chronic patients suffering from silent CVDs so that they can live longer and healthier lives?
- Can we better motivate patients to adhere to medication?
- Can we increase the ability of patients to adhere to medication?
- Can we find novel and non intrusive ways to trigger people to take their medication?
2Please refer to following article to learn more about BJ Fogg’s Behaviour Model.
Deadline: 20/12/2023
José Luís Lirio
Dir. U. Hospitals
Overview
Pain that a patient feels has two components: the objective component which is primarily the sensory response including the strength of signal sent to the brain and a subjective component which is a combination of cognitive, emotional and behavioural response that affects how the pain is perceived and reacted to. 1
The four responses (sensory, cognitive, emotional and behavioural) together create and modulate the intensity of pain felt by patients. Because pain is both physiological and psychological (i.e. psychophysiological) and hence personal to the individual, the current method of treatment which is somewhat generic and primarily focused on physiological aspects (i.e. sensory response) leaves a lot of room for improvement.
极光vpm破解无限版
How can we help patients suffering from chronic pain using digital solutions that enable them to have a better quality of life?
- Can we find a better and more objective way for patients to communicate the intensity of pain felt with doctors? Use cases: regular clinical practice, clinical trials, etc.
- Can we deliver targeted pain therapies digitally to patients leveraging one or more of the four responses above to reduce pain and dependence on drugs?
- Can we help patients, doctors and caregivers better track and monitor pain using digital technologies?
- Can we leverage digital technologies to build more connected pain therapy devices? Example: TENS 2
for chronic patients
Deadline: 20/12/2023
Eloi Torcal
Corporate product manager
Claudia Roca
Corporate marketing manager
Overview
Patients who suffer from severe chronic illnesses are often reliant on care givers in order to their maintain quality of life. This loss of freedom coupled with an already stressed care system in many parts of the world leads to a challenging life for many patients.
For example, PAH (Pulmonary Arterial Hypertension) patients currently have a bleak outlook as the disease is progressive and without cure. Patients live an average of 7-10 year from diagnosis and gradually see their mobility decreased. Patients eventually have to rely on continuous infusion pump therapy1 and are completely reliant on their support network (i.e. family members, doctors, nurses and physicians).
Challenge
How can we improve care, for chronic patients such as those suffering from advanced PAH symptoms and reduce the burden on their support network using digital solutions?
- Can we better track and monitor patients through a digitally enhanced solution?
- Can we provide guidance and troubleshoot common issues for patients digitally?
- Can we complement the patient support network, which is primarily face to face, though digital means?
- Can we help patients cope with pain and emotional distress using digital technologies?
- Can we reduce frequent patient visits to care centres for medicine collection and related tests?
Deadline: 20/12/2023
Carme Trepat
Head of Marketing
Overview
Half of the patients suffering from silent chronic cardiovascular diseases (CVD) stop taking their medication within 3 months of being diagnosed.1 The silent CVDs include coronary artery diseases, diabetes, cholesterol, hypertension and patients who are at an increased risk of heart attack and stoke (due to a previous event) and are now the leading cause of death.
In order for a person to take an action, three things need to happen first according to Dr. BJ Fogg (a psychologist and founder of Stanford Persuasive Technology Lab). First, the person needs to be motivated to perform the action. Second, the person needs to have the ability to perform that action. Finally, the person needs to have a trigger or a prompt which initiates the action2.
Most of the medical adherence solutions tend to focus on triggers through reminder applications etc. however the majority of non-adherence issues arise from lack of motivation or ability.
Challenge
How can we improve medication adherence using digital technologies for chronic patients suffering from silent CVDs so that they can live longer and healthier lives?
- Can we better motivate patients to adhere to medication?
- Can we increase the ability of patients to adhere to medication?
- Can we find novel and non intrusive ways to trigger people to take their medication?
2Please refer to following article to learn more about BJ Fogg’s Behaviour Model.
Deadline: 20/12/2023
José Luís Lirio
Dir. U. Hospitals
Overview
Pain that a patient feels has two components: the objective component which is primarily the sensory response including the strength of signal sent to the brain and a subjective component which is a combination of cognitive, emotional and behavioural response that affects how the pain is perceived and reacted to. 1
The four responses (sensory, cognitive, emotional and behavioural) together create and modulate the intensity of pain felt by patients. Because pain is both physiological and psychological (i.e. psychophysiological) and hence personal to the individual, the current method of treatment which is somewhat generic and primarily focused on physiological aspects (i.e. sensory response) leaves a lot of room for improvement.
Challenge
How can we help patients suffering from chronic pain using digital solutions that enable them to have a better quality of life?
- Can we find a better and more objective way for patients to communicate the intensity of pain felt with doctors? Use cases: regular clinical practice, clinical trials, etc.
- Can we deliver targeted pain therapies digitally to patients leveraging one or more of the four responses above to reduce pain and dependence on drugs?
- 会说话的汤姆猫,会说话的汤姆猫小游戏,360游娱司-360游戏库:2021-2-7 · 360游娱司,为您提供游戏热点资讯、热门游戏攻略、游戏专题等,包括小游戏、页游、网游、端游、手机游戏、电竞直播等内容,游戏爱好者伊在这里可伍快捷地找到想玩的游戏,为您业余生活添色 …
- Can we leverage digital technologies to build more connected pain therapy devices? Example: TENS 2
橡树vp官网
Mentorship
We train you and mentor you and give you access to members of Start-up Advisory Board.
Partnership
We will partner with you on an ad-hoc basis to help develop your solution and accelerate your growth.
极光vpm破解无限版
Access
We will serve as a reference for you and introduce you to stakeholders and leaders in the health industry.
Investment
We will provide funding to pilot the solution and reach a commercial agreement.
PROGRAM AT A GLANCE
SIGN-UP FOR A CHALLENGE
If you think you have a novel solution to one of our challenges, please apply by clicking on the "Apply" button below and choosing the specific challenge
25/05/2023
APPLICATION
OPENING
Submit your proposed solution to us by the posted deadline in no more than 10 slides.
极光vpm破解无限版
APPLICATION
DEADLINE
Q3 / 2023
INITIAL
PITCH
If shortlisted, you will be invited to deliver an initial pitch to us, 5-10 mins. We will evaluate you on five dimensions: need, competitive advantage, business model, team and compatibility with Ferrer.
Q4 / 2023
FINAL
PITCH
If successful, we will give you a chance to present your solution to our panel of experts in a final pitch, 1 hour. We will evaluate you on the five dimensions in greater depth as well as explore how f4F program can be adapted to your needs.
START DATE
DECEMBER 2023
WORK
WITH US
If we foresee a potential for collaboration, we will formally invite you to enrol into f4F program with ad hoc content and duration (3 to 18 months).
If you have a solution that doesn’t quite fit one of our challenges but would like to collaborate with us, we’d love to hear from you. Please tell us about your proposal by clicking the Collaborate With Us button and we will engage in conversation to learn more.
橡树vp官网
橡树vp官网
Barcelona, May 21st, 2023
Participating start-ups will be able to propose digital solutions for 3 challenges, the first one in the area of movement disorders, the second one in cognitive-behavioural disorders and the third one in chronic pain management.
And the winner is?
February 2023
Ferrer announces Wellthy Therapeutics as the winner of Ferrer 4 Future Winter Challenges 2023
Frontiers Health
13th-15th November 2023
We presented F4F program to the international entrepreneurs, investors, and media attending the Berlin-based conference.
Barcelona Tech City
5th November 2023
We discussed Ferrer's challenges with entrepreneurs at Pier 01, leading Digital Hub in Barcelona.
Come and meet us soon
橡树vp官网
橡树vp官网
- How to apply for a challenge?
- Who can apply for challenges?
- Can I apply to more than one challenge?
- What is the criteria for selection?
- How can I learn more about Ferrer 4 Future program?
- How many start-ups will be part of the program?
- What will happen to challenge winners?
- Who will finance my trips and stays in X city or Y country?
- How to apply for collaboration outside of challenges?
- Are you open for collaboration in areas other than movement disorders, cognitive behaviour disorders and pain?
- How long will the collaboration last?
- Is Ferrer 4 Future a venture fund/ arm of Ferrer?
- Whom can I contact if I have more questions?
- What to do if I have an IT issue?